Almac Group has appointed Dr. Stefan Mix to head of Biocatalysis. In his new role, he will be responsible for the development and application of platform technologies within Almac Sciences leading a team of almost 50 scientists, in addition to supporting and directing commercialization of new technology. 

Stefan joined the Almac Sciences business in April 2005 as a chemist working in the lab on process development projects for chiral materials and has been part of the biocatalysis team since its beginnings. He was promoted to Biocatalysis Team Leader in 2012.   

Professor Tom Moody, vice president of Technology Development & Commercialization, said, “Stefan’s wealth of knowledge, expertise and experience within biocatalysis and chemical synthesis has been critical to the success of our biocatalysis offering within Almac Sciences. I am delighted to announce Stefan’s promotion and wish him every success in his new role.”